Acta Group
- Home
- Companies
- Acta Group
- Services
- Endocrine Disruptors Services
Endocrine Disruptors Services
FromActa Group
Acta professionals routinely advise clients on a full range of endocrine disruptor issues, including registration and assessment.
Most popular related searches
endocrine disruptor
toxicity study
regulated chemical
reproductive toxicity study
chemical labeling
MTBE
toxicity assessment
chemical regulations
impact assessment
We offer the following expert services:
- Coordinate and oversee test programs to address EDSP Tier 1 and Tier 2 Test Orders
- Evaluate contract laboratories for compliance with GLP Standards and capabilities in endocrine disruptor screening testing
- Place, monitor, and evaluate studies conducted in accordance with accepted guidelines and GLP Standards
- Evaluate existing subchronic, reproductive, and/or developmental toxicity studies to assess potential endocrine disruption
- Prepare and submit EDSP studies, other scientifically relevant information (OSRI), and dossiers to EPA
- Assess the impacts of a chemical being identified as an endocrine disruptor
- Assist in the approval and regulation of chemical products
- Assist with reporting obligations for new and existing chemicals
- Assist with labeling and notice requirements
- Provide management services for companies interested in consortium approach for addressing advocacy needs and testing requirements related to List 1 and List 2 chemicals
BCCM currently manages two groups with chemicals on List 2 -- the N-Methylpyrrolidone (NMP) Producers Group, Inc. and the MTBE Consortium. BCCM engages with the groups` member companies to identify potential other producer or importer companies that should contribute to EDSP testing, outlining how cost shares will be allocated among participating companies and compiling relevant data and studies that can be used in "OSRI" submissions to EPA.
